Human NRG3 gene Map position 10q22-q23.

Chromosome Res

Center for Genomics Research and Microbiology & Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.

Published: February 2001

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1009232025144DOI Listing

Publication Analysis

Top Keywords

human nrg3
4
nrg3 gene
4
gene map
4
map position
4
position 10q22-q23
4
human
1
gene
1
map
1
position
1
10q22-q23
1

Similar Publications

Augmenting traditional genome-wide association studies (GWAS) with advanced machine learning algorithms can allow the detection of novel signals in available cohorts. We introduce "genome-wide association neural networks (GWANN)" a novel approach that uses neural networks (NNs) to perform a gene-level association study with family history of Alzheimer's disease (AD). In UK Biobank, we defined cases (n = 42 110) as those with AD or family history of AD and sampled an equal number of controls.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic pelvic pain (CPP) in women without clear pelvic issues lacks effective treatment options, as shown by a recent trial indicating gabapentin was ineffective and had more side effects compared to a placebo.
  • An exploratory study identified a significant genetic variant (rs4442490) linked to the response to gabapentin, suggesting this variant may influence how patients experience pain relief from the medication.
  • The genetic variant rs4442490 affects the expression of Neuregulin 3, which is important for brain function, particularly the orbitofrontal cortex, highlighting the potential for personalized treatment based on genetic factors.
View Article and Find Full Text PDF

Single-cell RNA sequencing of anaplastic ependymoma and H3K27M-mutant diffuse midline glioma.

BMC Neurol

February 2024

Department of Neurosurgery, Shenzhen Children's Hospital, 7019 Yitian Road, Futian District, Shenzhen, Guangdong, China.

Background: Anaplastic ependymoma and H3K27M-mutant diffuse midline glioma are two common subtypes of brain tumors with poor long-term prognosis. The present study analyzed and compared the differences in cell types between two tumors by single-cell RNA sequencing (scRNA-seq) technology.

Methods: ScRNA-seq was performed to profile cells from cancer tissue from anaplastic ependymoma patient and H3K27M-mutant diffuse midline glioma patient.

View Article and Find Full Text PDF

Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.

Acta Neuropathol Commun

November 2023

Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.

Article Synopsis
  • The study focuses on the progression of low-grade diffuse astrocytomas into grade 4 tumors and its impact on patient outcomes, highlighting the need for better understanding to enhance patient care.
  • Researchers analyzed genetic data from a cohort of patients with IDH-mutant astrocytomas, revealing significant alterations like increased chromosomal rearrangements and inactivation of key genes related to cell cycle regulation after treatment.
  • Results indicate that combined postoperative radiation and chemotherapy, especially temozolomide, may lead to improved survival outcomes, particularly in patients with grade 3 tumors, suggesting a need for more effective treatment strategies.
View Article and Find Full Text PDF

The etiology of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) is still obscure as are the processes that enable the progression of MGUS to MM. Understanding the unique vs. shared transcriptomes can potentially elucidate why individuals develop one or the other.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!